Heart Failure Risk Prediction in a Population With a High Burden of Diabetes: Evidence From the Strong Heart Study

Irene Martinez-Morata1, Arce Domingo-Relloso1,2, Ying Zhang3

  • 1Department of Environmental Health Sciences Mailman School of Public Health Columbia University New York NY USA.

Insights

Heart failure risk in American Indians is high. This study identified smoking, diabetes control (glycated hemoglobin), and kidney damage (albuminuria) as key predictors, improving risk assessment for this population.

Area of Science:

  • Cardiovascular epidemiology
  • Diabetes research
  • American Indian health

Background:

  • High burden of diabetes and cardiovascular risk factors in American Indian communities.
  • Scarcity of prospective heart failure (HF) studies in this population.
  • Limited generalizability of existing HF risk scales.

Purpose of the Study:

  • Develop a parsimonious HF risk prediction equation for American Indians.
  • Identify key risk factors for HF in this population, focusing on diabetes and kidney damage.

Main Methods:

  • Prospective study of 3059 participants from the Strong Heart Study (SHS).
  • Utilized Cox proportional hazards models to identify HF risk factors.
  • Follow-up up to 28 years.

Main Results:

  • Older age, smoking, macroalbuminuria, microalbuminuria, and previous myocardial infarction were significant HF predictors.
  • Diabetes diagnosis, glycated hemoglobin, and albuminuria were significant predictors at 10 and 28 years.
  • Achieved high discrimination performance (C-index 0.77-0.81).

Conclusions:

  • Smoking, body mass index, glycated hemoglobin, and albuminuria are major determinants of HF in American Indian communities.
  • Findings can improve HF risk assessment in populations with high diabetes burden.
  • Diabetes, albuminuria, and myocardial infarction were associated with all HF subtypes.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
324
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520